Skip to main content
. Author manuscript; available in PMC: 2022 Aug 18.
Published in final edited form as: Pharmacol Ther. 2009 Aug 5;124(2):248–257. doi: 10.1016/j.pharmthera.2009.07.005

Table 4.

Parameter values of the antagonist SCH 23390 binding to dopamine D1 receptors obtained by fitting data to different models.

5.0 nM [3H] SCH 23390 0.5 nM [3H] SCH 23390 0.1 nM [3H] SCH 23390

Model Parameters Values

Two-affinity statesa RH (%) 46 ± 1 28b ± 1 0
KDH (nM) 6 ± 1 11b ± 2 -
RL (%) 54 ± 1 72b ± 2 100c
KDL (nM) 460 ± 20 440 ± 10 320c ± 10
Two state dimer RT (pmol/mg protein) 0.499 ± 0.001 0.499 ± 0.001 0.501 ± 0.001
KDB1 (nM) 21 ± 5 18 ± 2 22 ± 4
KDB2 (nM) 390 ± 30 410 ± 30 420 ± 20
KDAB (nM) 18 ± 1 19 ± 3 23 ± 5
D C −0.67 −0.75 −0.68
B50 (nM) 90 86 96

Competition curves were simulated as indicated in the legend of Fig. 4. Parameter values were obtained by fitting three data point sets simulated considering a random experimental error in the range of ± 2.5%. RH and RL are, respectively, the % of maximum specific binding corresponding to high and low affinity sites and KDH and KDL are the equilibrium dissociation constants of the competing ligand (SKF 38393) for, respectively, high and low affinity sites. RT is the total amount of receptor dimers, KDB1 and KDB2 are, respectively, the equilibrium dissociation constants of the first and second binding of SKF 38393 to a dimer. KDAB is the hybrid equilibrium dissociation constant of SKF 38393 binding to a receptor dimer semi-occupied by [3H]SCH 23390. DCB is the “dimer cooperativity” index for the binding of ligand SKF 38393 and B50 is the concentration providing half saturation. Parameter values are mean ± s.e.m.

a

F test indicated that a significant improvement is obtained by assuming two-affinity states (compared to one-affinity state) except at 0.1 nM [3H]SCH 23390.

b

p<0.05 compared with values obtained at 5 nM [3H]SCH 23390 concentration.

c

p<0.05 compared with values obtained at 5 and 0.5 nM [3H]SCH 23390 concentration.